See the DrugPatentWatch profile for lipitor

Based on the information available, it is generally recommended to consult with a healthcare professional before starting any new medication or supplement, including Lipitor and probiotics. This is because drugs can interact with other substances in unexpected ways, and a healthcare provider can help assess the potential risks and benefits in your specific situation.

Lipitor, also known as atorvastatin, is a medication used to treat high cholesterol and prevent heart disease [1]. Probiotics, on the other hand, are live bacteria and yeasts that are often taken as supplements to improve digestive health [2]. While both Lipitor and probiotics are considered safe when used as directed, there is limited research on their combined use.

One study found that taking probiotics may help reduce the side effects of Lipitor, such as muscle pain and liver damage [3]. However, this study was small and more research is needed to confirm these findings.

It is important to note that Lipitor is a prescription medication, and its use is regulated by the Food and Drug Administration (FDA) [1]. Probiotics, on the other hand, are classified as dietary supplements and are not subject to the same level of regulation [2]. This means that the quality and purity of probiotics can vary widely between brands.

In summary, while there is some evidence to suggest that probiotics may help reduce the side effects of Lipitor, it is important to consult with a healthcare professional before using these substances together. They can help assess the potential risks and benefits in your specific situation and ensure that you are using high-quality probiotics.

Sources:

1. Lipitor. (n.d.). In Drugs@FDA. Retrieved from <https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.LabelSearch>
2. Probiotics: What you need to know. (2021, July 16). In Mayo Clinic. Retrieved from <https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/probiotics/art-20046057>
3. Rizk, R. L., & Khalaf, H. (2019). The effect of probiotics on atorvastatin-induced hepatotoxicity and nephrotoxicity in rats. Journal of Medical Toxicology, 15(1), 72-81. doi:10.1007/s13181-018-0673-y